← All stocks

Karyopharm Therapeutics Inc.

KPTI Net selling
CIK 0001503802 #4777 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$38.38
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$38.38
1 of 1 sales
Net
−$38.38
−$38.38 against sales at will

By person

13 insiders · 1 transaction
0.7×

Richard Paulson holds only 0.7 times base salary in stock. $544.89K of shares against $770.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Paulson last reported holding, valued at $2.02, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Abate Kristin
Chief Accounting Officer
$38.38 (1)
−$38.38
23,782
$48.04K
+99.1%
Paulson Richard A.
President and CEO
269,747
$544.89K
+187.8%
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
107,940
$218.04K
+276.3%
Poulton Stuart
EVP, Chief Development Officer
94,632
$191.16K
+246.7%
Mano Michael
EVP, CLO&Secretary
94,398
$190.68K
+417.1%
Macomber Lori
EVP, CFO & Treasurer
85,105
$171.91K
Rangwala Reshma
EVP & Chief Medical Officer
56,829
$114.79K
+148.6%
BOHLIN GAREN G
Director
18,517
$37.40K
+515.4%
Greene Barry E
Director
16,415
$33.16K
+1,710%
Oliger Christy J.
Director
15,508
$31.33K
PAKIANATHAN DEEPIKA
Director
15,508
$31.33K
Su Zhen
Director
15,508
$31.33K
Schor Chen
Director
15,508
$31.33K

No percentages here. This company's share count has moved by a factor of 1,973.5 over the window, from 8,639,904 to 17,050,876,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Abate Kristin
1 Sep 2026
Chief Accounting Officer
Sell
19
$2.02
$38.38

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 8 Nov 2016